InvestorsHub Logo
Followers 73
Posts 17543
Boards Moderated 0
Alias Born 09/03/2001

Re: peregrinus post# 271142

Monday, 08/29/2016 4:41:03 PM

Monday, August 29, 2016 4:41:03 PM

Post# of 345694
STEVEN KING

Steven KingPresident & CEO
Peregrine Pharmaceuticals
ONLINE PROFILE

Steve King was appointed President and CEO of Peregrine Pharmaceuticals in March 2003 and has led the company into three Phase II clinical programs. Mr. King joined the company in 1997 as Director of R&D. In 2000, Steve was responsible for bringing the company’s biomanufacturing facility into full cGMP compliance and then launching Peregrine’s subsidiary Avid Bioservices. Prior to joining Peregrine, Steve worked with a company that was developing Vascular Targeting Agents and with UT Southwestern Medical Center with the inventor of Peregrine’s technology. Steve holds BS and MS degrees in Biology from Texas Tech University.


SEMINARS

viewing 1 - 1 of 1
22 Sep 2016
09:50 - 10:20
Analysing the business and partnering model in industry and academia for the future development of immuno-oncology combination therapies
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News